These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20735469)

  • 1. Balance is the challenge--the impact of mitochondrial dynamics in Parkinson's disease.
    Burbulla LF; Krebiehl G; Krüger R
    Eur J Clin Invest; 2010 Nov; 40(11):1048-60. PubMed ID: 20735469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
    Büeler H
    Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in Parkinson's disease.
    Zhu J; Chu CT
    J Alzheimers Dis; 2010; 20 Suppl 2():S325-34. PubMed ID: 20442495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial injury: a hot spot for parkinsonism and Parkinson's disease?
    Giasson BI
    Sci Aging Knowledge Environ; 2004 Dec; 2004(48):pe42. PubMed ID: 15576821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis.
    Dagda RK; Chu CT
    J Bioenerg Biomembr; 2009 Dec; 41(6):473-9. PubMed ID: 20012177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
    Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
    J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.
    Henchcliffe C; Beal MF
    Nat Clin Pract Neurol; 2008 Nov; 4(11):600-9. PubMed ID: 18978800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila.
    Park J; Kim Y; Chung J
    Dis Model Mech; 2009; 2(7-8):336-40. PubMed ID: 19553694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial quality control and dynamics in Parkinson's disease.
    McCoy MK; Cookson MR
    Antioxid Redox Signal; 2012 May; 16(9):869-82. PubMed ID: 21568830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The gene products for familial Parkinson's disease provide us hints to elucidate the mechanisms of nigral degeneration].
    Hattori N
    Rinsho Shinkeigaku; 2004 Nov; 44(11):821-3. PubMed ID: 15651302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial metabolic control of microtubule dynamics impairs the autophagic pathway in Parkinson's disease.
    Cardoso SM; Esteves AR; Arduíno DM
    Neurodegener Dis; 2012; 10(1-4):38-40. PubMed ID: 22156537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.
    Pienaar IS; Dexter DT; Burkhard PR
    Expert Rev Proteomics; 2010 Apr; 7(2):205-26. PubMed ID: 20377388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in Parkinson's disease.
    Winklhofer KF; Haass C
    Biochim Biophys Acta; 2010 Jan; 1802(1):29-44. PubMed ID: 19733240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases.
    Mandemakers W; Morais VA; De Strooper B
    J Cell Sci; 2007 May; 120(Pt 10):1707-16. PubMed ID: 17502481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.